title: Reduction of renal function by angiotensin-converting enzyme inhibitors: effect of verapamil.
authors.forename: R
authors.initials: R
authors.lastname: Bitar
authors.forename: B
authors.initials: B
authors.lastname: Martín
authors.forename: J M
authors.initials: JM
authors.lastname: López-Novoa
authors.forename: J F
authors.initials: JF
authors.lastname: Macías-Nuñez
mesh_terms: D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000139:chemically induced / Q000209:etiology; D008297:Male; D014700:Verapamil / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D014700:Verapamil